Head-To-Head Survey: OptimizeRx (NASDAQ:OPRX) vs. Teladoc Health (NYSE:TDOC)

Teladoc Health (NYSE:TDOC) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Insider & Institutional Ownership

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 7.5% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Teladoc Health and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
OptimizeRx	4.66%	9.44%	7.11%

Valuation & Earnings

This table compares Teladoc Health and OptimizeRx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.49 billion	0.40	-$200.32 million	($0.99)	-5.59
OptimizeRx	$98.65 million	1.64	$5.13 million	$0.23	37.26

OptimizeRx has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Teladoc Health and OptimizeRx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1	10	5	0	2.25
OptimizeRx	1	2	6	0	2.56

Teladoc Health presently has a consensus target price of $7.54, suggesting a potential upside of 36.12%. OptimizeRx has a consensus target price of $11.57, suggesting a potential upside of 35.02%. Given Teladoc Health’s higher probable upside, equities analysts plainly believe Teladoc Health is more favorable than OptimizeRx.

Volatility and Risk

Teladoc Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Summary

OptimizeRx beats Teladoc Health on 10 of the 14 factors compared between the two stocks.

About Teladoc Health

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.